UBS Group’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.37M | Sell |
274,940
-164,437
| -37% | -$819K | ﹤0.01% | 4113 |
|
2025
Q1 | $1.94M | Buy |
439,377
+205,978
| +88% | +$908K | ﹤0.01% | 3720 |
|
2024
Q4 | $1.09M | Buy |
233,399
+134,254
| +135% | +$624K | ﹤0.01% | 4156 |
|
2024
Q3 | $688K | Sell |
99,145
-372,311
| -79% | -$2.58M | ﹤0.01% | 3869 |
|
2024
Q2 | $3.68M | Buy |
471,456
+108,506
| +30% | +$846K | ﹤0.01% | 2357 |
|
2024
Q1 | $2.58M | Buy |
362,950
+350,643
| +2,849% | +$2.49M | ﹤0.01% | 2760 |
|
2023
Q4 | $82.5K | Sell |
12,307
-2,650
| -18% | -$17.8K | ﹤0.01% | 5091 |
|
2023
Q3 | $84.2K | Sell |
14,957
-272,077
| -95% | -$1.53M | ﹤0.01% | 4831 |
|
2023
Q2 | $1.58M | Sell |
287,034
-4,149
| -1% | -$22.9K | ﹤0.01% | 2882 |
|
2023
Q1 | $1.82M | Sell |
291,183
-294,417
| -50% | -$1.84M | ﹤0.01% | 2680 |
|
2022
Q4 | $2.73M | Buy |
585,600
+61,127
| +12% | +$285K | ﹤0.01% | 2306 |
|
2022
Q3 | $2.45M | Buy |
524,473
+34,710
| +7% | +$162K | ﹤0.01% | 2211 |
|
2022
Q2 | $2.9M | Buy |
489,763
+143,929
| +42% | +$852K | ﹤0.01% | 2139 |
|
2022
Q1 | $6.69M | Buy |
345,834
+21,515
| +7% | +$416K | ﹤0.01% | 1715 |
|
2021
Q4 | $10.6M | Sell |
324,319
-251,492
| -44% | -$8.22M | ﹤0.01% | 1513 |
|
2021
Q3 | $23.6M | Sell |
575,811
-233,950
| -29% | -$9.6M | 0.01% | 1024 |
|
2021
Q2 | $29.2M | Sell |
809,761
-143,875
| -15% | -$5.18M | 0.01% | 901 |
|
2021
Q1 | $37.2M | Buy |
953,636
+451,376
| +90% | +$17.6M | 0.01% | 755 |
|
2020
Q4 | $20.3M | Buy |
502,260
+492,239
| +4,912% | +$19.9M | 0.01% | 1006 |
|
2020
Q3 | $557K | Buy |
+10,021
| New | +$557K | ﹤0.01% | 3332 |
|